Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved]
Africa bears the brunt of many of the world’s most devastating human and animal infectious diseases, a good number of which have no licensed or effective vaccines available. The continent’s potential to generate novel interventions against these global health threats is however largely untapped. Str...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-07-01
|
| Series: | AAS Open Research |
| Online Access: | https://aasopenresearch.org/articles/1-18/v1 |
| _version_ | 1797710308369760256 |
|---|---|
| author | George M. Warimwe Jyothi Purushotham Brian D. Perry Adrian V.S. Hill Sarah C. Gilbert Baptiste Dungu Bryan Charleston |
| author_facet | George M. Warimwe Jyothi Purushotham Brian D. Perry Adrian V.S. Hill Sarah C. Gilbert Baptiste Dungu Bryan Charleston |
| author_sort | George M. Warimwe |
| collection | DOAJ |
| description | Africa bears the brunt of many of the world’s most devastating human and animal infectious diseases, a good number of which have no licensed or effective vaccines available. The continent’s potential to generate novel interventions against these global health threats is however largely untapped. Strengthening Africa’s vaccine research and development (R&D) sector could accelerate discovery, development and deployment of effective countermeasures against locally prevalent infectious diseases, many of which are neglected and have the capacity to spread to new geographical settings. Here, we review Africa’s human and veterinary vaccine R&D sectors and identify key areas that should be prioritized for investment, and synergies that could be exploited from Africa’s veterinary vaccine industry, which is surprisingly strong and has close parallels with human vaccine R&D. |
| first_indexed | 2024-03-12T06:50:18Z |
| format | Article |
| id | doaj.art-8b79fc8e73f14dfd933325205521180a |
| institution | Directory Open Access Journal |
| issn | 2515-9321 |
| language | English |
| last_indexed | 2024-03-12T06:50:18Z |
| publishDate | 2018-07-01 |
| publisher | F1000 Research Ltd |
| record_format | Article |
| series | AAS Open Research |
| spelling | doaj.art-8b79fc8e73f14dfd933325205521180a2023-09-03T00:21:27ZengF1000 Research LtdAAS Open Research2515-93212018-07-01110.12688/aasopenres.12877.113943Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved]George M. Warimwe0Jyothi Purushotham1Brian D. Perry2Adrian V.S. Hill3Sarah C. Gilbert4Baptiste Dungu5Bryan Charleston6Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, KenyaThe Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UKThe Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UKThe Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UKThe Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UKM.C.I. Santé Animale, Mohammedia, 28810, MoroccoThe Pirbright Institute, Woking, GU24 0NF, UKAfrica bears the brunt of many of the world’s most devastating human and animal infectious diseases, a good number of which have no licensed or effective vaccines available. The continent’s potential to generate novel interventions against these global health threats is however largely untapped. Strengthening Africa’s vaccine research and development (R&D) sector could accelerate discovery, development and deployment of effective countermeasures against locally prevalent infectious diseases, many of which are neglected and have the capacity to spread to new geographical settings. Here, we review Africa’s human and veterinary vaccine R&D sectors and identify key areas that should be prioritized for investment, and synergies that could be exploited from Africa’s veterinary vaccine industry, which is surprisingly strong and has close parallels with human vaccine R&D.https://aasopenresearch.org/articles/1-18/v1 |
| spellingShingle | George M. Warimwe Jyothi Purushotham Brian D. Perry Adrian V.S. Hill Sarah C. Gilbert Baptiste Dungu Bryan Charleston Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] AAS Open Research |
| title | Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] |
| title_full | Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] |
| title_fullStr | Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] |
| title_full_unstemmed | Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] |
| title_short | Tackling human and animal health threats through innovative vaccinology in Africa [version 1; peer review: 2 approved] |
| title_sort | tackling human and animal health threats through innovative vaccinology in africa version 1 peer review 2 approved |
| url | https://aasopenresearch.org/articles/1-18/v1 |
| work_keys_str_mv | AT georgemwarimwe tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT jyothipurushotham tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT briandperry tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT adrianvshill tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT sarahcgilbert tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT baptistedungu tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved AT bryancharleston tacklinghumanandanimalhealththreatsthroughinnovativevaccinologyinafricaversion1peerreview2approved |